Clinical trials
Infections clinical trials
Below are recruiting infections clinical trials, each written for real people, not researchers. We’re tracking 1,767 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06679140RecruitingPhase 3
Study of Ibuzatrelvir for COVID-19 in high-risk patients
This trial tests if a new medicine called ibuzatrelvir can help people with COVID-19 who have certain health risks avoid severe illness. It is for patients who cannot or choose not to take another COVID-19 pill called Paxlovid.
Little Rock, ArkansasAges 12 years+ - NCT07708727RecruitingPhase 2/Phase 3
Injectable HIV treatment vs daily pill for new patients
This trial tests a new injectable HIV treatment (GS-3242 plus lenacapavir) compared to the daily pill Biktarvy for people just starting HIV therapy. If you qualify, you would receive shots every few weeks instead of taking a daily pill.
Ft. Pierce, FloridaAges 18 years+ - NCT07650916RecruitingPhase 3
A study of two ultra-long-acting HIV shots
This trial tests a new ultra-long-acting injectable combination of cabotegravir and rilpivirine for people with HIV who already have the virus under control. It aims to see if these shots can keep the virus suppressed with fewer doses.
Phoenix, ArizonaAges 12 years+ - NCT07763054Recruiting
Low-dose antifungal prevention for patients with low white blood cell counts
This trial tests a low dose of an antifungal medicine (liposomal amphotericin B) to prevent fungal infections in patients whose white blood cell counts are very low for more than a week. It may help patients who are at high risk for fungal infections and cannot take other antifungal drugs.
Hainan, HainanAges 18–75 - NCT07285785RecruitingPhase 4
Rifaximin for children with acute diarrhea
This study tests whether a medicine called rifaximin, taken along with oral rehydration solution, helps children aged 6 to 11 recover faster from acute (short-lasting) diarrhea that is likely caused by a bacterial infection. The study compares rifaximin plus oral rehydration versus oral rehydration alone.
Lynwood, CaliforniaAges 6–12 - NCT07029997Recruiting
Follow-up study of the Solo+ ear tube device
This study checks how well the Solo+ ear tube device works over time. If you or your child had the device placed to help with ear infections or fluid buildup, joining helps doctors learn how it performs.
Trieste, Trieste (TS)Ages 6 months+ - NCT07706686RecruitingPhase 1
Dengue challenge study in people with prior infection
This study tests how the body responds to a mild, lab-made dengue virus in people who have had dengue before. It looks at how the immune system reacts to a second infection, which may help improve future vaccines and treatments.
Bethesda, MarylandAges 18–50 - NCT07453966Recruiting
Lung vibration therapy for people on breathing machines with lung infection
This study tests a device that delivers gentle vibrations to the lungs to help clear infection in people who are on a breathing machine. It may help improve oxygen levels and recovery.
Wuhan, HubeiAges 18 years+ - NCT07696364Recruiting
Testing a mouthwash for gum health
This trial tests a special mouthwash (chlorhexidine) to see how well it prevents gum inflammation. It compares a standard version to one that also reduces tooth staining. You may be eligible if you are healthy, do not smoke, and have at least 24 teeth with healthy gums.
Bern, Canton of BernAges 18–40 - NCT00344188Recruiting
Study of Leishmania infections
This trial studies people with Leishmania infections (a parasitic disease often from sand fly bites). Researchers aim to better understand and treat the infection, and you may benefit from expert care.
Bethesda, MarylandAges 3–100 - NCT07610395RecruitingPhase 2
Testing an oral drug for cold virus in COPD patients
This trial tests an oral medication (VPV) to see if it can safely treat rhinovirus (a common cold virus) in people with COPD. The goal is to help you recover faster and prevent serious COPD flare-ups.
Mobile, AlabamaAges 40–85 - NCT07758140Recruiting
At-home cervical cancer screening study
This study tests if women can collect their own samples at home to screen for cervical cancer, which could make screening easier and more comfortable. You would provide a sample and compare it to a standard doctor-collected sample.
Phoenix, ArizonaAges 25–65 - NCT06495021Recruiting
Osteopathic manipulation for newly diagnosed respiratory illness in older adults
This study tests whether osteopathic manipulation (a gentle hands-on treatment) helps older adults recover from common respiratory illnesses like bronchitis or pneumonia when added to regular care. It may be a good option for you if you're 65 or older and have just been diagnosed with a respiratory infection.
Bloomsburg, PennsylvaniaAges 65–100 - NCT05350813Recruiting
Using procalcitonin to stop antibiotics earlier safely
This study tests whether a blood test called procalcitonin can help doctors stop intravenous antibiotics earlier in young hospitalized children when an infection seems likely. The goal is to reduce unnecessary antibiotic exposure without missing serious infections.
AmiensAges 3 days–17 years - NCT07336134Recruiting
HPV self-test for cervical health
This study offers a way to screen for cervical cancer using an HPV self-test. It is designed for women who may not have had a recent Pap smear and are from certain minority groups.
Philadelphia, PennsylvaniaAges 25–65 - NCT07214571RecruitingPhase 2
Study of S-337395 for RSV in high-risk adults
This trial tests an experimental drug called S-337395 for adults with RSV who are not in the hospital but are at high risk for severe illness. It aims to see if the drug can help prevent symptoms from getting worse.
Los Angeles, CaliforniaAges 18 years+ - NCT07085702RecruitingPhase 1
Testing a new Strep A vaccine in healthy young adults
This study tests a new vaccine designed to protect against Group A Strep bacteria. It will check how safe the vaccine is and how well it boosts your immune system. Healthy young adults between 18 and 25 years old may be eligible.
Botany, New South WalesAges 18–25 - NCT07756554Recruiting
Care at the nursing home instead of hospital
This trial tests whether treating nursing home residents at their nursing home, instead of sending them to the hospital, is a good alternative. It aims to see if this approach can improve care and avoid unnecessary hospital visits.
CopenhagenAges 18 years+ - NCT06310551RecruitingPhase 1
Long-acting HIV prevention study for healthy adults
This study tests a new long-acting medicine that may help prevent HIV. It is given as an injection, and the study checks how safe it is and how it works in healthy volunteers.
Lenexa, KansasAges 18–55 - NCT07383649RecruitingPhase 2
Anti-CMV therapy for breast cancer with brain metastases
This trial tests a treatment targeting a common virus (CMV) in breast cancer that has spread to the brain. The goal is to see if anti-CMV therapy can shrink or slow these brain tumors.
Houston, TexasAges 18 years+ - NCT06805656RecruitingPhase 2
Trial to reduce HIV reservoirs aiming for treatment-free remission
This study tests whether a combination approach, including a drug called nicotinamide (a form of vitamin B3) and other strategies, can reduce the hidden HIV reservoir enough to allow a temporary pause in antiretroviral therapy without the virus rebounding. It is for people who have well-controlled HIV and strong immune systems.
São Paulo, São PauloAges 18–65 - NCT01780168Recruiting
Study of metabolism, infection, and immunity in mitochondrial disease
This study looks at how metabolism, infections, and the immune system work together in people with mitochondrial disease. It aims to learn more about the condition and may help guide future treatments.
Bethesda, MarylandAges 4 weeks–115 years - NCT07600983RecruitingPhase 1/Phase 2
New pneumococcal vaccine safety and effectiveness study
This trial tests a new vaccine designed to protect against 24 types of pneumococcal bacteria (which cause pneumonia and other serious infections). Researchers are checking if it's safe and how well it works in infants, children, and adults.
ShangqiuAges 1 month+ - NCT07397689Recruiting
Early Sepsis Detection Tool for Children
This trial checks if a new tool can help doctors spot sepsis early in children. If your child is under 18, had a blood culture, and received strong antibiotics within the first day in the hospital, they may qualify.
ShanghaiAges Up to 18 years
Hear when a new Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infections?
- Yes. Clin2 currently lists 1,767 recruiting infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.